Matthias Mack
Geboren:
1969
Hat mitgewirkt an:
-
Entwicklung rekombinanter bispezifischer single-chain Antikörper zur Tumortherapie mit Hilfe von T Lymphozyten
-
Monocytes Elicit a Neutrophil-Independent Th1/Th17 Response Upon Immunization With a Mincle-Dependent Glycolipid Adjuvant
-
The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients
-
Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction